{
  "trial_id": "NCT02630706",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, body mass index (BMI), baseline A1C, duration of type 2 diabetes mellitus, baseline metformin dose, baseline blood pressure, renal function (serum creatinine, estimated glomerular filtration rate), liver function (AST, ALT, total bilirubin), history of cardiovascular events, concomitant medications, smoking status, alcohol consumption, baseline lipid profile (cholesterol, triglycerides).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Weight",
          "body mass index (BMI)"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "baseline A1C"
        ],
        [
          "Baseline estimated glomerular filtration rate (eGFR)",
          "renal function (serum creatinine, estimated glomerular filtration rate)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Baseline Fasting Plasma Glucose (FPG)",
        "Country",
        "Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)",
        "Gender (China Substudy)",
        "Body Weight (China Substudy)",
        "Baseline A1C (China Substudy)",
        "Baseline FPG (China Substudy)",
        "Baseline eGFR (China Substudy)",
        "Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)"
      ],
      "remaining_candidate_features": [
        "duration of type 2 diabetes mellitus",
        "baseline metformin dose",
        "baseline blood pressure",
        "liver function (AST, ALT, total bilirubin)",
        "history of cardiovascular events",
        "concomitant medications",
        "smoking status",
        "alcohol consumption",
        "baseline lipid profile (cholesterol, triglycerides)"
      ]
    },
    "processed-gen-response": "Age, sex, body mass index (BMI), baseline A1C, duration of type 2 diabetes mellitus, baseline metformin dose, baseline blood pressure, renal function (serum creatinine, estimated glomerular filtration rate), liver function (AST, ALT, total bilirubin), history of cardiovascular events, concomitant medications, smoking status, alcohol consumption, baseline lipid profile (cholesterol, triglycerides)."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Blood Pressure, Serum Creatinine, Estimated Glomerular Filtration Rate (eGFR), Aspartate Transaminase (AST), Alanine Transaminase (ALT), Total Bilirubin, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Weight",
          "Body Mass Index"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "Baseline HbA1c"
        ],
        [
          "Baseline estimated glomerular filtration rate (eGFR)",
          "Estimated Glomerular Filtration Rate (eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Baseline Fasting Plasma Glucose (FPG)",
        "Country",
        "Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)",
        "Gender (China Substudy)",
        "Body Weight (China Substudy)",
        "Baseline A1C (China Substudy)",
        "Baseline FPG (China Substudy)",
        "Baseline eGFR (China Substudy)",
        "Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Diabetes",
        "Blood Pressure",
        "Serum Creatinine",
        "Aspartate Transaminase (AST)",
        "Alanine Transaminase (ALT)",
        "Total Bilirubin"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Blood Pressure, Serum Creatinine, Estimated Glomerular Filtration Rate (eGFR), Aspartate Transaminase (AST), Alanine Transaminase (ALT), Total Bilirubin"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, HbA1c, Diabetes Duration, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, History of Cardiovascular Disease, History of Hypertension, History of Hyperlipidemia.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Weight",
          "Body Mass Index"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "HbA1c"
        ],
        [
          "Baseline estimated glomerular filtration rate (eGFR)",
          "eGFR"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Baseline Fasting Plasma Glucose (FPG)",
        "Country",
        "Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)",
        "Gender (China Substudy)",
        "Body Weight (China Substudy)",
        "Baseline A1C (China Substudy)",
        "Baseline FPG (China Substudy)",
        "Baseline eGFR (China Substudy)",
        "Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Diabetes Duration",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "History of Cardiovascular Disease",
        "History of Hypertension",
        "History of Hyperlipidemia"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, HbA1c, Diabetes Duration, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, History of Cardiovascular Disease, History of Hypertension, History of Hyperlipidemia."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), type 2 diabetes mellitus duration, HbA1C at baseline, metformin dose at baseline, systolic blood pressure, diastolic blood pressure, estimated glomerular filtration rate (eGFR), aspartate transaminase (AST), alanine transaminase (ALT), total bilirubin, serum creatinine.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Body Weight",
          "body mass index (BMI)"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "HbA1C at baseline"
        ],
        [
          "Baseline estimated glomerular filtration rate (eGFR)",
          "estimated glomerular filtration rate (eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Country",
        "Anti-hyperglycemic Agent (AHA) Status at Screening (Metformin Alone OR Metformin + Another AHA)",
        "Gender (China Substudy)",
        "Body Weight (China Substudy)",
        "Baseline A1C (China Substudy)",
        "Baseline Fasting Plasma Glucose (FPG)",
        "Baseline FPG (China Substudy)",
        "Baseline eGFR (China Substudy)",
        "Anti-AHA status at Screening (Metformin Alone OR Metformin + Another AHA) (China Substudy)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "type 2 diabetes mellitus duration",
        "metformin dose at baseline",
        "systolic blood pressure",
        "diastolic blood pressure",
        "aspartate transaminase (AST)",
        "alanine transaminase (ALT)",
        "total bilirubin",
        "serum creatinine"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), type 2 diabetes mellitus duration, HbA1C at baseline, metformin dose at baseline, systolic blood pressure, diastolic blood pressure, estimated glomerular filtration rate (eGFR), aspartate transaminase (AST), alanine transaminase (ALT), total bilirubin, serum creatinine."
  }
}